BODIPY-labeled CRBN in complex with damage-specific DNA-binding protein 1 (DDB1) harboring an internal deletion of the flexible β propeller B domain (DDB1ΔB-CRBN)22 and in vitro–biotinylated BTK were treated with increasing concentrations of the indicated compounds in the presence of tracer amounts of terbium-streptavidin. Compound-induced recruitment of BTK to CRBN was quantified following the 520/490 time-resolved fluorescence resonance energy transfer (FRET) ratio22 using a Pherastar plate reader (BMG) utilizing 2 synchronized photomultiplier tubes to reduce background.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.